Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
Stopped Sponsor has designed another study with different endpoint to replace the current study
Conditions
Interventions
- DRUG: rhNRG-1
- DRUG: Placebo
Sponsor
Zensun Sci. & Tech. Co., Ltd.